MASS SPECTROMETRY TECHNOLOGIES TO ADVANCE CARE FOR CANCER PATIENTS IN CLINICAL AND INTRAOPERATIVE USE. Issue 5 (23rd October 2020)

• Record Type: Journal Article
• Authors: Zhang, Jialing; Sans, Marta; Garza, Kyana Y.; Eberlin, Livia S.
• Is Part Of: Mass spectrometry reviews. Volume 40:Issue 5(2021)
• Page Start: 692
• Page End: 720
• Publication Date: 2020-10-23
• Subjects: Mass spectrometry -- Periodicals; 543
• DOI: 10.1002/mas.21664
• Languages: English
• ISSNs: 0277-7037

Abstract

Abstract : Developments in mass spectrometry technologies have driven a widespread interest and expanded their use in cancer‐related research and clinical applications. In this review, we highlight the developments in mass spectrometry methods and instrumentation applied to direct tissue analysis that have been tailored at enhancing performance in clinical research as well as facilitating translation and implementation of mass spectrometry in clinical settings, with a focus on cancer‐related studies. Notable studies demonstrating the capabilities of direct mass spectrometry analysis in biomarker discovery, cancer diagnosis and prognosis, tissue analysis during oncologic surgeries, and other clinically relevant problems that have the potential to substantially advance cancer patient care are discussed. Key challenges that need to be addressed before routine clinical implementation including regulatory efforts are also discussed. Overall, the studies highlighted in this review demonstrate the transformative potential of mass spectrometry technologies to advance clinical research and care for cancer patients. © 2020 Wiley Periodicals, Inc. Mass Spec Rev